{"transactions":[{"id":1152919,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-12T20:48:31.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":37975,"derivative":{"exercise_price":3.88,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-069626","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017025069626/ownership.xml","form_type":"4"}},{"id":1282790,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-05T19:24:18.000Z","date":"2025-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.49,"value":1743.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower."}],"balance_after":2819,"source":{"system":"sec-edgar","filing":"0000950170-25-014802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017025014802/ownership.xml","form_type":"4"}},{"id":1426961,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T18:09:33.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":25475,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-099593","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017024099593/ownership.xml","form_type":"4"}},{"id":1428322,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:05:54.000Z","date":"2024-08-01","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.06,"value":1442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":2119,"source":{"system":"sec-edgar","filing":"0000950170-24-099335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017024099335/ownership.xml","form_type":"4"}},{"id":1659946,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-05T16:29:56.000Z","date":"2024-02-01","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.06,"value":1442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to February 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":1419,"source":{"system":"sec-edgar","filing":"0000950170-24-011271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017024011271/ownership.xml","form_type":"4"}},{"id":1814185,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-07T19:55:36.000Z","date":"2023-08-04","kind":"purchase","planned":false,"acquired":true,"shares":649,"price":3.67,"value":2381.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 649 shares of the Issuer's common stock on 8/1/23 at a per share purchase price of $3.67 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to August 1, 2023. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":719,"source":{"system":"sec-edgar","filing":"0001209191-23-044889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123044889/doc4.xml","form_type":"4"}},{"id":1911720,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T17:24:47.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":5475,"derivative":{"exercise_price":7.55,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-23-026079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123026079/doc4.xml","form_type":"4"}},{"id":2037285,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-02T19:07:29.000Z","date":"2023-02-01","kind":"purchase","acquired":true,"shares":700,"price":0.23,"value":161.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/23 at a per share purchase price of $0.23 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to February 1, 2023. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":2800,"source":{"system":"sec-edgar","filing":"0001209191-23-006429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123006429/doc4.xml","form_type":"4"}},{"id":2064355,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-05T21:07:57.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 1/3/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":159000,"derivative":{"exercise_price":0.28,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-002182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123002182/doc4.xml","form_type":"4"}}]}